ERBB2 and breast carcinoma: We investigated drug-induced autophagy in breast cancer cell lines with differing ER/PR/Her2 status by exposing them to tamoxifen (MCF-7), trastuzumab (SKBR-3), bortezomib and rapamycin (MDA-MB-231) in presence and absence of chloroquine to capture early signs of autophagy flux.